Seattle genetics inc. reports earnings results for the third quarter ended september 30, 2019

Seattle genetics inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 213.263 million compared to usd 169.424 million a year ago. operating loss was usd 89.784 million compared to usd 45.574 million a year ago. net loss was usd 91.913 million compared to usd 67.446 million a year ago. basic loss per share was usd 0.55 compared to usd 0.42 a year ago. for the nine months, total revenue was usd 626.909 million compared to usd 480.187 million a year ago. operating loss was usd 182.131 million compared to usd 169.687 million a year ago. net loss was usd 184.480 million compared to usd 102.888 million a year ago. basic loss per share was usd 1.13 compared to usd 0.66 a year ago.
SGEN Ratings Summary
SGEN Quant Ranking